摘要
支气管哮喘(简称哮喘)是一种具有异质性的气道慢性炎症性疾病。哮喘患者在哮喘药物的治疗中也表现出明显的异质性。编码β2肾上腺素能受体的ADRB2基因突变可以影响哮喘的易感性、表型和疗效,本文就ADRB2基因多态性与哮喘的研究进展进行综述。
Bronchial asthma (asthma) is a heterogeneous chronic inflammatory airway disease. Asthmatic patients also showed significant heterogeneity in the treatment. The ADRB2 gene encoding beta 2 adrenergic receptor mutations are associated with the asthmatic susceptibility, phenotype and response to medication. This article reviewed the research progress between the ADRB2 gene polymorphisms and asthma.
作者
代思思
邱志新
李为民
Dai Sisi;QiuZhixin;Li Weimin(Department of Pulmonary and Critical Care,West China Hospital,Sichuan University,Chengdu 610041,China)
出处
《国际呼吸杂志》
2018年第19期1495-1498,共4页
International Journal of Respiration